2/16/2022

speaker
Operator

Welcome to InnoSpec's earnings call for the quarter and year-ended December 31st, 2021. The earnings released in this presentation are posted on the company's site at InnoSpecInc.com. During this call, we will make forward-looking statements, which are predictions, projections, and other statements about future events. These statements are based on current expectations and assumptions that are subject to risk and uncertainties that could cause actual results to differ materially from the anticipated results implied by forward-looking statements. These risks and uncertainties are detailed in InnoSpec 10-K, 10-Q, and other filings with the SEC. Please see the SEC site or InnoSpec site for these and other documents. In our discussions today, we've also included some non-GAAP financial measures. A reconciliation is the most directly comparable GAAP financial measures contained in our earnings release. The non-GAAP financial measures should not be considered as a substitute for or superior to those prepared in accordance with GAAP. They are included as additional clarification items to aid investors in further understanding the company's performance in addition to the impact that these items have on financial results. With us today from Inispec are Patrick Williams, President and Chief Executive Officer, and Ian Clementson, Executive Vice President and Chief Financial Officer. Pat, I'll turn it over to you, Patrick.

speaker
Patrick Williams

Thank you, David, and welcome everyone to Inispec's fourth quarter 2021 conference call. I am pleased to present another very strong set of quarterly results for Innispec. Despite sustained supply chain, labor, and inflationary headwinds, we ended the year with record quarterly sales and full-year operating income up 74% on the prior year. Cash flow was extremely strong in the quarter, and our net cash position improved to $140 million. In addition, Today, we announced that our board has approved a new $50 million share repurchase program. I'm extremely proud of the way our InnoSpec team has navigated this year's volatile market conditions to deliver these strong set of quarterly results and full-year results. Our business teams remain safe, resourceful, and customer-focused throughout this challenging year. We believe we are entering 2022 well-positioned for continued innovation and growth in all our businesses. Performance Chemicals achieved record quarterly sales and surpassed a half a billion dollars in full-year sales for the first time. The business delivered its fourth consecutive year of operating income growth and margin expansion with full-year operating income up an impressive 29% over 2020. With our $70 million organic growth investment plans in motion and our new state-of-the-art global technology center on track for completion by Q2 of this year, we are well positioned to meet our customers' growing technology demands. Customers and consumers want sustainability, but they also want high performance. This dual requirement will continue to drive exciting technology-led future growth opportunities across all our performance chemical and markets. Fuel specialties achieved record quarterly and full year sales along with improved operating leverage. Gross margins ran below our target 32% to 35% range, but this was primarily due to continued delay in jet fuel demand recovery, sales mix, and contract formula price increases, which naturally lag cost inflation. As jet fuel demand continues to recover and cost inflation moderates, we expect gross margins to return to our target range. Consistent with our performance chemicals business, the majority of our current sales and future growth opportunities in fuel specialties are directly tied to sustainability. I am proud of the role that InnoSpec's technology plays in directly addressing these global initiatives to deploy cleaner fuels and increase fuel economy. Our technology adds critical safety, emission reduction, and performance properties to diesel, renewable, and distillate fuels. As society moves towards cleaner fuels, tighter emission standards, and higher efficiency engines, our addressable market expands. The global drive to find cost-effective ways to reduce emissions, burn cleaner fuels, and increase operational efficiency plays directly to our technology leadership. Oilfield services grew sales and expanded operating margin for the sixth consecutive quarter. The overall market environment in terms of commodity prices Completion and production activity is expected to continue to improve in 2022. As in the prior quarter, with this backdrop, there continues to be significant potential for operating growth. Now I will turn the call over to Ian Clemson, who will review our financial results in more detail. Then I will return with some concluding comments. After that, Ian and I will take your questions.

speaker
David

Thanks, Patrick. Turning to slide seven in the presentation, the company's total revenues for the fourth quarter were 413.2 million, a 33% increase from 310.8 million a year ago, driven by recovering demand in all our businesses compared to a COVID-impacted prior year. Overall, group's margin decreased by two percentage points from last year to 27.3%. EBITDA for the quarter was 44.8 million compared to 40.2 million last year, and net income for the quarter was 23.9 million compared to 22.6 million a year ago. Our gap earnings per share were 96 cents, including special items, the net effect of which decreased our fourth quarter earnings by 34 cents per share. A year ago, we reported gap earnings per share of 91 cents, which included the negative impact from special items of 36 cents per share. Excluding special items in both years, our adjusted EPS for the quarter was $1.30 compared to $1.27 a year ago. For the full year, total revenues of $1.5 billion increased 24% from $1.2 billion in 2020. EBITDA for the year was $178.2 million compared to $108.9 million in 2020 and net income was $93.1 million compared to $28.7 million a year ago. Our full year gap earnings per share were $3.75, including special items, which decreased our full year earnings by $1.05 per share. In 2020, we reported gap earnings of $1.16 per share, which included the negative impact on special items of $2.06 per share. Excluding special items in both years, our adjusted EPS for the year was $4.80, compared to $3.22 a year ago. Turning to slide 8, revenues in performance chemicals for the fourth quarter were $138.4 million, up 21% from last year's $114.6 million. Volumes grew 2%, with a positive price mix of 21%, offsetting an adverse currency impact of 2%. Gross margins of 21.4%, were down 2.4 percentage points compared to 23.8% same quarter in 2020, impacted by the slowdown of our manufacturing facilities over the holiday period and one-off inventory provisions. We expect gross margins to return to 24% in Q1 2022. Operating income increased 16% from last year to 16.9 million. For the full year, Performance Chemicals revenues of £525.3 million, were up 23% from last year's £425.4 million, and operating income increased by 29% to £70.9 million. Moving on to slide 9, revenues in fuel specialties for the fourth quarter were £179.5 million, 30% higher than the £138.3 million reported a year ago. Volumes grew by 10%, and there was a positive price mix effect of 22%, offsetting a negative currency impact of 2%. Fuel Specialty's gross margins for the quarter were below our expected range at 27.4%, compared to 31.4% in the same quarter in 2020, driven by a weaker sales mix and contract formula price increases, which naturally lag cost inflation. We believe gross margins will return to 32% being the lower end of our expected range in Q1 2022 as pricing action takes effect. Operating income increased 1% from last year to 25.7 million. For the full year, fuel specialties revenues were up 21% to 618.3 million and operating income was up 24% to 104.6 million. Moving on to slide 10, Revenues in oilfield services for the quarter were 95.3 million, up 65% from 57.9 million in the fourth quarter last year, as customer activity continues to increase. Gross margins of 35.9% were up 0.8 percentage points on last year's 35.1%. Operating income of 4.3 million was a 4.1 million improvement from a year ago. For the full year, oilfield services revenues of £339.8 million were up 33% from last year's £255 million, an operating income of £10.4 million compared to an operating loss of £9.5 million in 2020. Turning to slide 11, corporate costs for the quarter were £13.2 million compared with £10.7 million a year ago, due mainly to higher compensation accruals. The full year adjusted effective tax rate was 22.7% compared to 23.5% a year ago, due mainly to the geographical distribution of profits. For 2022, we expect the adjusted effective tax rate to be 24%. Moving on to slide 12, this was another excellent quarter for cash, with cash generated from operations of 68.8 million before net capital expenditure of 9.2 million. In the quarter, we paid the previously announced semi-annual dividend of 59 cents per common share. This brought the total dividend for the full year to $1.16 per share, a 12% increase over 2020. For the full year, cash from operations after net capital expenditure was 57 million compared to 116.2 million during 2020. As of December 31st, 2021, NSBIC had net cash of $141.7 million, a substantial improvement compared to net cash of $104.7 million a year ago. And now I'll turn it back over to Patrick for some final comments.

speaker
Patrick Williams

Thanks, Ian. Entering 2022, we expect tight supply chain and elevated cost inflation to continue. It is imperative that our business teams maintain their sharp focus on technology, customer service, pricing, and gross margin management. We are cautiously optimistic that these conditions will moderate in the coming quarters, and we are well positioned for continued growth and margin expansion in all businesses. Our portfolio is dominated by technologies that are critical to the performance of personal care, cleaning, and other daily use applications, including more sustainable and cleaner transportation. Further price increases have been announced in all businesses in the first quarter. And in parallel, we continue to introduce innovative products which can help offset the impact of higher prices to our customers through enhanced performance. Our businesses did an excellent job managing cash and working capital during the quarter, increasing our net cash position to over $140 million. We will continue to create value for our shareholders through our disciplined execution of our capital allocation programs. These include funding our well-defined pipeline or Regenit growth projects, pursuing complementary acquisitions, and increasing capital returns to shareholders through dividend growth in our newly announced $50 million share buyback facility. Now I will turn the call over to the operator, and Ian and I will take your questions.

speaker
Ian

Thank you. As a reminder, to ask a question, you need to press star 1 on your telephone. To withdraw your question, press the pound hash key. Your first question today comes from the line of John Tamwanteng from CJS Securities. Please go ahead. Your line is open. Hi.

speaker
John Tamwanteng

Thank you. Good morning, everyone. Really nice order, especially on the domestic pricing side. I was wondering, can you talk about your high-level expectations for pricing versus volume as components of your revenue growth in each of the segments as we go forward? I assume there's more pricing coming, but I'm wondering on the volume side of that expectation specifically, what are you thinking there as we enter Q1 into 2022?

speaker
David

Yeah, John, let me start off with that one, then I'm sure Patrick will come over with some comments. So just going through the individual businesses, as we've been talking throughout 2021, we're really pleased with where performance chemicals is, it's in a really sweet spot and we're expecting high single digit growth and we expect most of that growth to come through volume. Now there will be a raw material impact that will inflate those revenues a little bit like they have done in 2021 but underlying in the business we expect high single digit growth mainly through volume. Fuel Specialties is slightly different. Fuel Specialties has now reached back to that pre-COVID diesel demand globally. We've still got a little bit more to come in terms of volume from jet fuel, but that will come slowly throughout 2022. So you may well see a little bit more volume in Fuel Specialties, but overall, that's a business that will settle back into that low single-digit growth rates. Again, we'll see some price inflation in the revenue line there, but underlying, you will expect to see probably 1% to 2% volume growth in that business. Oil field is really the one where we're a little bit uncertain at the moment. Customer activity is slowly returning. We're capturing our share of the market, and we'd expect the business to perform better than it has done in 2021. So again, we're optimistic that we'll continue to see good volume growth there as well.

speaker
Patrick Williams

Yeah, I think, John, it's nice to see volume growth versus just pricing activity. And it's been consistent throughout all three businesses, as Ian alluded to. So we're pretty confident. We're very happy with the quarter, and we're very happy with the year-end results.

speaker
John Tamwanteng

Okay, great. Thank you for that color. And it's also nice to see that you're expecting gross margin improvement in Q1. I was wondering if you could actually talk about OpEx as we go forward as well as Is there inflation that you need to address there as well, especially in terms of wage inflation and employee retention?

speaker
David

Yeah, John, like everybody else in the industry and the wider economy, we are seeing a lot of wage inflation. We're seeing a lot of raw material inflation, freight, trucking, you name it. It's all coming through. And we're very clear that our people are our key asset. We want to do everything we can. to attract the best talent and retain the best talent. So we're taking action across all of our businesses around wages and working conditions and flexibility. So yeah, you'll see us do a lot more of that. How that impacts our operating expenses, we've baked all that into our numbers. It will add some pressure onto operating margins, but we think it's the right thing to do and we'll take the correct action whichever part of the world we're operating in.

speaker
John Tamwanteng

Okay, great. Just a question on the buyback authorization. Is that more of an opportunistic thing, you know, where you're waiting for some opportunity, or is that something you plan to execute rather quickly on, you know, just given what the alternatives are in your capital allocation, you know, strategy?

speaker
Patrick Williams

You know, it's a little bit of both, John. You know, it's being opportunistic in the marketplace. It's preventing dilution. It's a little bit of both, and I think that you'll see that because we have such a balanced capital allocation program, that this is easily manageable. And we would like to see this continue moving forward as the years move on. So I think we're in a good spot. We've really identified a great growth program in performance chemicals over the next five years where our capital allocation is going. We've increased the dividend between 10% to 12% every year. We want to continue doing that. And I think along with a nice share buyback and potentially increasing over time as well, puts us in a really good position.

speaker
John Tamwanteng

Got it. And one final moment for me, if I could just be 70 million in an ounce investment. Can you break that out between, you know, product lines and, and markets and kind of what you're actually putting the money into?

speaker
David

Yeah, John, let me, uh, let me take that as a first go. Um, so the 70 millions over, uh, just over two years worth of investments for us, uh, and we're investing both in, uh, the U S and Europe. We're investing across a number of our facilities. The primary focus of that initially will be in the personal care markets, but we'll also be investing capacity into our home care markets, and that will also support our growing business in agriculture and industrial and mining as well. So the primary focus will be personal care, and that's the part of the business that we're seeing the most growth right now. But we're not just blind to the other parts of that business as well. So, you know, most of that will go into capacity expansions and the infrastructure that's needed around our plants to manage that growth, be it tanking, piping, or whatever it might be. So there's an awful lot going on, John. It's a multi-year program, and we're well on with it right now. And that's what's going to support that high single-digit growth, not just into 2022, but also into 2023 and 2024 and beyond.

speaker
Patrick Williams

Yeah, and I think just to add to that, John, it's all based around sustainability, natural, etc., And that's really been the themes all along, and that's the theme of our growth moving forward. And I think, as Ian said, typically when we add expansion and add reactors, that volume is typically already spoken for. And so it's a really nice program that's put in place with some nice contracts to back it, and it's all based around sustainability, long-term sustainability, and natural.

speaker
John Tamwanteng

Got it. Thanks, guys. I'll jump back in the queue. Thank you. Thanks, Joe.

speaker
Ian

Thank you. I will now hand the call back to Patrick Williams for closing remarks.

speaker
Patrick Williams

Thank you all for joining us today, and thanks to all our shareholders, customers, and InnoSpec employees for your interest and support. If you have any further questions about InnoSpec or matters discussed today, please give us a call. We look forward to meeting up with you again to discuss our first quarter 2022 results in May. Have a great day.

Disclaimer

This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

-

-